SS
IRWD icon

SBI Securities’s Ironwood Pharmaceuticals IRWD Stock Holding History

SBI Securities’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.51K Buy
1,286
+1,220
+1,848% +$5K ﹤0.01% 2069
2025
Q4 		$222 Sell
66
-2
-3% -$5 ﹤0.01% 3175
2025
Q3 		$89 Sell
68
-2
-3% -$2 ﹤0.01% 3548
2025
Q2 		$50 Buy
70
+7
+11% +$5 ﹤0.01% 3720
2025
Q1 		$93 Sell
63
-4
-6% -$10 ﹤0.01% 3465
2024
Q4 		$297 Buy
+67
New +$272 ﹤0.01% 3094

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SBI Securities's IRWD Position: Q1 2026 in Review

SBI Securities increased its Ironwood Pharmaceuticals (IRWD) stake by 1,848% in Q1 2026, buying an estimated $5K and bringing the position to 1,286 shares worth $4.51K. The position accounts for ﹤0.01% of the portfolio, ranked #2069.

SBI Securities first reported a position in IRWD in Q4 2024 and has held it in 6 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • SBI Securities held 1,286 shares of Ironwood Pharmaceuticals worth $4.51K as of Q1 2026.
  • SBI Securities bought 1,220 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $5K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2069 holding.
  • SBI Securities first reported a position in Ironwood Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.